MedTrace Logo

Evaluating Mental Health Improvements After Using Home Phototherapy Device With UVB LEDs

NCT05235334 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2023-04-25

No results posted yet for this study

Summary

The primary objective of this study is to evaluate the satisfaction of users with the MySOLIUS device by a non-professional in a home use environment. The secondary objective of this study is to demonstrate the safety and effectiveness of the MySOLIUS device in the improvement of mood/quality of life score.

Conditions

  • Usability
  • Quality of Life

Interventions

DEVICE

MySOLIUS

MySOLIUS is a portable light therapy device that is designed to deliver a small amount of targeted ultraviolet B (UVB) light to trigger the body's natural production of vitamin D.

Sponsors & Collaborators

  • BeneSol, Inc. dba SOLIUS

    lead INDUSTRY

Principal Investigators

  • Jashin J Wu, MD · Office of Jashin Wu, M.D.

  • Chih-ho Hong, MD · Dr. Chih-ho Hong Medical Inc.

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-12
Primary Completion
2023-04-12
Completion
2023-04-12
FDA Device
Yes

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05235334 on ClinicalTrials.gov